Although the specific ligands under conditions of NAFLD‐NASH in activating the MD2‐TLR4 have yet to be identified, our data obtained from HepG2 cells indicated that PA is likely one contributing TLR4 ligand. The gene discussed is LY96; the disease is metabolic dysfunction-associated steatotic liver disease.